1-3 of 3
Nina Khoroshko, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of Imatinib Plasma Level in the Achievment of Complete Cytogenetic Response (CCyR) in Chronic Myeloid Leukemia (CML) Therapy

Sergey Kutsev, MD, PhD, Oxana Oxenjuk, MD, Sergey Mordanov, MD, Yuri Shatokhin, MD, PhD, Tatiana Pospelova, MD, PhD, Nina Khoroshko, MD, PhD, Anna Turkina, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3789.
https://doi.org/10.1182/blood.V118.21.3789.3789
Published: 2011
Journal Articles

Results of Tyrosine Kinase Inhibitors (TKI) Therapy of Patients (Pts) with Chronic Myeloid Leukemia (CML) In Clinical Practice Analysed In the Frame of International Research Project EUTOS In Russian Federation

Anna G. Turkina, MD, PhD, Sergey Kulikov, Kudrat Abdulkadirov, Sergey Kutsev, MD, PhD, Anatoly Golenkov, MD, Valentina Ivanova, Tatiana Pospelova, MD, PhD, Tatiana Konstantinova, Olga Lazareva, PhD, Nina Khoroshko, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4447.
https://doi.org/10.1182/blood.V118.21.4447.4447
Published: 2011
Journal Articles

Clinical Significance of Additional Chromosomal Abnormalities In Ph-Positive and Ph-Negative Cells In Patients with Chronic Myeloid Leukemia Treated by Tyrosine Kinase Inhibitors

Anna G. Turkina, MD, PhD, Olga Vinogradova, PhD, Alexandra Vorontsova, PhD, Ekaterina Chelysheva, PhD, Olga Lazareva, PhD, Galina Gusarova, PhD, Elena Aseeva, PhD, Nina Khoroshko, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1683.
https://doi.org/10.1182/blood.V118.21.1683.1683
Published: 2011